MedLife turnover reached 332 million Euro, up 51.6 percent in 2021

MedLife Group announces last year’s financial results. In 2021, the company registered pro-forma consolidated turnover of 1,632 million RON (332 million Euro) with 51.6 percent higher than in 2020 and an almost two folded net profit, amounting to RON 123 million, increasing by 93 percent. Operating revenues amounted to RON 1,647 million, up 51.6 percent compared to 2020, while operating expenses reached RON 1,460 million, up 49.4 percent.

In 2021, MedLife Group continued its strategy of expansion through acquisitions, and investments were directed towards supporting strategic objectives aimed at research, strengthening the area of radiotherapy and oncology, amplifying the process of digitization and territorial expansion, the budget invested last year exceeding 30 million Euro.

According to the company’s representatives, all business lines followed an upward trend in 2021, with notable performances for the division of laboratories, clinics, hospitals, but also for dentistry and pharmacies.

“We have reached a level of maturity that confirms that MedLife is a sustainable and replicable business model, a performance recognized by the recent inclusion of the company in FTSE Russell indices. We are enthusiastic that we have completed the partnership with NeoLife Romania, being the 36th transaction successfully completed at group level. We currently have discussions in advanced stages for 3 large transactions and another 5 small ones and we aim to complete by the end of this year. In fact, the investment budget planned for the next period is 100-120 million Euro and we intend to allocate approximately 50-70 million Euro for transactions in Romania and in the countries in the region”, said Mihai Marcu, President and CEO of MedLife Group.

The development and expansion plan for 2022 follows the route Cluj-Napoca, Timisoara, Constanta, openings of new clinics in Muntenia and Translivania, but also in other regions of the country, with the aim of consolidating the national coverage in the next 2 years.